Open Beta
MetriLume

US marketsNEPH

SEC-sourced researchBeta

NEPH

NEPHROS INC

Company comparison ↗

Data passport

CIK
0001196298
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Sep 16, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 14,162,000.0000 USD; December 2025: 18,789,000.0000 USD18.8M USD0 USD0December 2024December 2025
NEPH · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202414,162,000.0000Mar 12, 2026
December 202518,789,000.0000Mar 12, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202518,789,000.00001,194,000.00001,645,000.000013,641,000.00003,439,000.0000Mar 12, 2026
December 202414,162,000.000074,000.0000-492,000.000011,210,000.00002,625,000.0000Mar 12, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$18.79MDecember 2025Mar 12, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$14.16MDecember 2024Mar 12, 202610-K
Net incomeNetIncomeLoss$1.19MDecember 2025Mar 12, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$1.65MDecember 2025Mar 12, 202610-K
Total assetsAssets$13.64MDecember 2025Mar 12, 202610-K
Total liabilitiesLiabilities$3.44MDecember 2025Mar 12, 202610-K

New filings

Explore methodology ↗